References►
1.
Kishi T, Fujita N, Eguchi T, and Ueda K. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci
145: 109–112, 1997.
2. McNamara J. Drugs effective in the therapy of the epilepsies. As cited in Goodman L and Gilman A. The pharmacological basis of therapeutics, 9th ed. Hardman J, et al., eds. New York: McGraw-Hill, 1996: 472.
3.
Reynolds EH, et al. Anti-convulsant therapy, megaloblastic haematopoesis, and folic acid metabolism.
Quart J Med
35: 521–537, 1966.
4.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism
46: 959–962, 1997.
5.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain
91: 197–214, 1968.
6.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc
95: 352–356, 1995.
7.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother
32: 802–817, 1998.
8.
Biale Y and Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs.
Eur J Obstet Gynecol Reprod Biol
18: 211–216, 1984.
9.
Holmes T and Kummerow F. The relationship of adequate and excessive intake of vitamin D to health and disease.
J Am Coll Nutr
2: 173–199, 1983.
10. Shils M, et al., eds. Modern nutrition in health and disease. 9th ed. Baltimore: Williams and Wilkins, 1999: 1634.
11.
Wahl TO, Gobrity AH, and Lukert BP. Long-term anticonvulsant therapy and intestinal calcium absorption.
Clin Pharmacol Ther
30: 506–512, 1981.
12.
Cornelissen M, Steegers-Theunissen R, Kolle L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol
168: 923–928, 1993.
13.
Cornelissen M, Steegers-Theunissen R, Kolle L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency.
Am J Obstet Gynecol
168: 884–888, 1993.
14.
Krause K-H, Bonjour J-P, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci
447: 297–313, 1985.
15.
Said HM, Redha R, and Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr
49: 127–131, 1989.
16.
Bourgeois BFD, Dodson WE, and Ferrendelli JA. Interactions between primidone, carbamazepine, and nicotinamide.
Neurology
32: 1122–1126, 1982.
17.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548–551, 1996.
18.
Mizuno N, Kawakami K, and Morita E. Competitive inhibition between 4'-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain.
J Nutr Sci Vitaminol (Tokyo)
26: 535–543, 1980.
19.
Wada K, Ishigaki S, Ueda K, et al. An antivitamin B
6, 4'-methoxypyridoxine, from the seed of
Ginkgo biloba
L.
Chem Pharm Bull (Tokyo)
33: 3555–3557, 1985.
20.
Yagi M, Wada K, Sakata M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese; English abstract].
Yakugaku Zasshi
113: 596–599, 1993.
21.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548–551, 1996.
